Reuters logo
BRIEF-Tyme says has identified mechanism and related biomarker could potentiate calcification of tumors​
October 25, 2017 / 3:08 PM / in 24 days

BRIEF-Tyme says has identified mechanism and related biomarker could potentiate calcification of tumors​

Oct 25 (Reuters) - Tyme Technologies Inc

* Tyme Technologies Inc - has identified mechanism and related biomarker that co believes could potentiate calcification of tumors​

* Tyme - during evaluation of lead product candidate, observed subsequent to SM-88 therapy some lytic bone lesions converted to benign sclerotic bone​

* Tyme Technologies Inc - ‍ believes it has isolated cause of conversion of some lytic bone lesions to benign sclerotic bone subsequent to SM-88 therapy​

* Tyme Technologies Inc - ‍confirmed ability to calcify osteosarcoma tumors in canine models​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below